Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$225.07 - $246.17 $281,787 - $308,204
1,252 Added 22.21%
6,890 $1.61 Million
Q1 2024

May 03, 2024

SELL
$233.45 - $247.73 $1.63 Million - $1.73 Million
-6,971 Reduced 55.29%
5,638 $1.4 Million
Q4 2023

Feb 09, 2024

BUY
$232.24 - $267.23 $550,408 - $633,335
2,370 Added 23.15%
12,609 $3.07 Million
Q3 2023

Nov 13, 2023

SELL
$254.9 - $283.59 $579,642 - $644,883
-2,274 Reduced 18.17%
10,239 $2.65 Million
Q2 2023

Aug 03, 2023

BUY
$238.39 - $265.32 $971,200 - $1.08 Million
4,074 Added 48.28%
12,513 $3.3 Million
Q1 2023

May 12, 2023

BUY
$229.71 - $259.35 $152,297 - $171,949
663 Added 8.53%
8,439 $2.09 Million
Q4 2022

Feb 13, 2023

BUY
$218.29 - $256.91 $770,781 - $907,149
3,531 Added 83.18%
7,776 $1.98 Million
Q3 2022

Nov 07, 2022

SELL
$51.03 - $264.23 $15,411 - $79,797
-302 Reduced 6.64%
4,245 $946,000
Q2 2022

Aug 12, 2022

BUY
$234.74 - $275.42 $636,849 - $747,214
2,713 Added 147.93%
4,547 $1.12 Million
Q1 2022

May 11, 2022

BUY
$243.64 - $270.48 $446,835 - $496,060
1,834 New
1,834 $488,000
Q4 2020

Feb 12, 2021

SELL
$221.92 - $245.94 $194,180 - $215,197
-875 Closed
0 $0
Q3 2020

Nov 09, 2020

BUY
$215.77 - $276.76 $188,798 - $242,165
875 New
875 $204,000
Q1 2020

May 11, 2020

SELL
$195.69 - $279.01 $2.25 Million - $3.2 Million
-11,479 Closed
0 $0
Q4 2019

Mar 19, 2020

BUY
$236.45 - $266.82 $104,274 - $117,667
441 Added 4.0%
11,479 $3.12 Million
Q3 2019

Mar 19, 2020

SELL
$230.58 - $256.08 $17.9 Million - $19.9 Million
-77,558 Reduced 87.54%
11,038 $2.79 Million
Q2 2019

Mar 19, 2020

SELL
$217.4 - $246.08 $860,904 - $974,476
-3,960 Reduced 4.28%
88,596 $22.3 Million
Q1 2019

Mar 19, 2020

BUY
$206.05 - $248.17 $2.35 Million - $2.83 Million
11,411 Added 14.06%
92,556 $23.1 Million
Q4 2018

Mar 19, 2020

SELL
$204.73 - $257.93 $6.8 Million - $8.57 Million
-33,220 Reduced 29.05%
81,145 $18.3 Million
Q3 2018

Mar 19, 2020

SELL
$233.07 - $256.0 $5.94 Million - $6.52 Million
-25,485 Reduced 18.22%
114,365 $29.8 Million
Q2 2018

Mar 19, 2020

BUY
$208.1 - $233.85 $1.37 Million - $1.54 Million
6,600 Added 4.95%
139,850 $33.5 Million
Q1 2018

Mar 19, 2020

BUY
$205.46 - $240.27 $2.67 Million - $3.12 Million
13,000 Added 10.81%
133,250 $28.9 Million
Q4 2017

Mar 19, 2020

BUY
$189.0 - $222.64 $12.5 Million - $14.8 Million
66,300 Added 122.89%
120,250 $25.7 Million
Q3 2017

Mar 19, 2020

SELL
$186.89 - $198.9 $74,756 - $79,560
-400 Reduced 0.74%
53,950 $10.6 Million
Q2 2017

Mar 19, 2020

SELL
N/A
-51,200 Reduced 48.51%
54,350 $10.6 Million
Q1 2017

Mar 19, 2020

BUY
N/A
48,200 Added 84.05%
105,550 $19.4 Million
Q4 2016

Mar 19, 2020

SELL
N/A
-24,100 Reduced 29.59%
57,350 $9.49 Million
Q3 2016

Mar 19, 2020

SELL
N/A
-63,250 Reduced 43.71%
81,450 $14.6 Million
Q2 2016

Mar 19, 2020

SELL
N/A
-59,000 Reduced 28.96%
144,700 $24.5 Million
Q1 2016

Mar 19, 2020

BUY
N/A
2,500 Added 1.24%
203,700 $30.9 Million
Q4 2015

Mar 19, 2020

BUY
N/A
1,400 Added 0.7%
201,200 $31 Million
Q3 2015

Mar 19, 2020

BUY
N/A
31,600 Added 18.79%
199,800 $26.5 Million
Q2 2015

Mar 19, 2020

BUY
N/A
168,200
168,200 $23.8 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Bi Asset Management Fondsmaeglerselskab A Portfolio

Follow Bi Asset Management Fondsmaeglerselskab A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.